(Q44632352)

4 December 2017

title

Influence of losartan and atenolol on memory function in very elderly hypertensive patients (English)

1 reference

4 December 2017

1 reference

1 reference

4 December 2017

Fogari R

1 reference

4 December 2017

Mugellini A

1 reference

4 December 2017

Zoppi A

1 reference

4 December 2017

Pasotti C

1 reference

4 December 2017

Fogari E

1 reference

4 December 2017

Preti P

1 reference

4 December 2017

publication date

1 November 2003

1 reference

Journal of Human Hypertension

4 December 2017

published in

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

781-785

1 reference

A population-based study on the incidence of dementia disorders between 85 and 88 years of age.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Cognitive impairment in elderly people: population based estimate of the future in England, Scotland, and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Relation of Blood Pressure to Cognitive Function in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Low blood pressure and dementia in elderly people: the Kungsholmen project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Cognitive impairment and mortality in a cohort of elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

The effects of antihypertensive treatment on cognitive function: results from the HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Effects of mild cardiovascular and cerebrovascular disorders on serial reaction time performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

WAIS Performance for Different Age Groups of Hypertensive and Control Subjects during the Administration of a Diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Letter: Methyldopa and forgetfulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Impairment of memory function by antihypertensive medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

A comparison of verapamil and nifedipine on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Impaired learning and memory in mature spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

The Set Test as an Aid to the Detection of Dementia in Old People

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Angiotensin receptors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

The role of angiotensin II in cognition and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Role of the angiotensin II type-2 receptor in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Involvement of nitric oxide-formation in the action of losartan (DuP 753): effects in an inhibitory avoidance model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

15-year longitudinal study of blood pressure and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

7 January 2021

Blood pressure and cognitive performance. The Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

7 January 2021

Blood pressure and cognitive function in healthy old people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

7 January 2021

Slowing of response time in young and middle-aged hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

7 January 2021

Clinical significance of cognitive performance by hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001613

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001613

1 reference

4 December 2017

1 reference